Location: San Francisco, CA
CIK: 0001524362 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value: $167M (36.0% shares, 64.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | BANDWIDTH INC | 40,250,000 | $32.48M | 19.5% | $0.62 | — | NOTE 0.500% 4/0 | 05988JAD5 |
| — | SUMMIT HOTEL PPTYS | 29,039,000 | $27.79M | 16.7% | $0.96 | — | NOTE 1.500% 2/1 | 866082AA8 |
| ONTF | ON24 INC | 4,240,256 | $22.05M | 13.2% | $22.91 | -72.9% | COM | 68339B104 |
| — | ACCELERATE DIAGNOSTICS INC | 37,049,299 | $18.52M | 11.1% | $0.59 | — | NOTE 5.000%12/1 | 00430HAC6 |
| — | IRONWOOD PHARMACEUTICALS INC | 17,000,000 | $15.08M | 9.1% | $0.90 | — | NOTE 1.500% 6/1 | 46333XAH1 |
| — | EQUITY COMWLTH | 8,403,411 | $13.53M | 8.1% | $10.55 | — | COM SH BEN INT | 294628102 |
| — | TRAVERE THERAPEUTICS INC | 13,000,000 | $12.78M | 7.7% | $0.99 | — | NOTE 2.500% 9/1 | 761299AB2 |
| BLKB | BLACKBAUD INC | 193,000 | $11.98M | 7.2% | $71.07 | 0.0% | COM | 09227Q100 |
| ESPR | ESPERION THERAPEUTICS INC NE | 3,000,000 | $4.32M | 2.6% | $2.33 | -21.0% | COM | 29664W105 |
| BATRK | ATLANTA BRAVES HLDGS INC | 93,811 | $3.753M | 2.3% | $39.01 | 0.0% | COM SER C | 047726302 |
| EMBC | EMBECTA CORP | 221,938 | $2.83M | 1.7% | $15.31 | 0.0% | COMMON STOCK | 29082K105 |
| ADV | ADVANTAGE SOLUTIONS INC | 980,865 | $1.481M | 0.9% | $2.33 | 0.0% | COM CL A | 00791N102 |